Coxsackievirus B5-induced severe mucocutaneous reaction mimicking drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis
Sir, Group B coxsackieviruses cause hand-foot-and-mouth disease and herpangina. Recently, enterovirus and Coxsackie A6 virus induced severe mucocutaneous reactions resembling drug-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), both clinically and histopathologically, have been reported. 1, 2 Here, we report the first case of coxsackievirus B5-induced severe mucocutaneous reaction mimicking drug-induced SJS/TEN.
A 12-year-old apparently healthy boy presented to our emergency department with a 2-day history of generalized skin rashes. It was preceeded by fever and rhinorrhea since last 6 days. Congested/painful eyes and multiple buccal ulcers developed subsequently. He was initially diagnosed with herpangina. However, maculopapular rashes developed on his trunk, with rapid progression to extremities and face. He reported past treatment with ibuprofen, acetaminophen, dextromethorphan, diclofenac, cephalexin and sulfamethoxazole eye drops, without any appreciable benefit. Initially, ibuprofen, diclofenac, and cephalexin were suspected to be the culprit agents for suspected drug eruptions. However, absence of similar symptoms during previous treatment with these drugs refuted our suspicion.
Physical examination revealed widespread, dusky-red, purpuric, maculopapular rashes with vesicles on the face, trunk, extremities, palms, and soles [ Figure 1 ]; conjunctival hyperemia with purulent discharge resulting in eyelid adhesion [ Figure 2a] ; ulcers on his buccal mucosa and hard palate; and crusted hemorrhagic erosions on the lips [ Figure 2b ], scrotum, and glans penis. Hair and nails were spared. Initial differential diagnoses included drug-induced SJS/TEN, Mycoplasma pneumoniae-induced rash and mucositis, erythema multiforme major, and atypical hand-foot-and-mouth disease.
Laboratory investigations revealed elevated c-reactive protein level (22.4 mg/dL) without leukocytosis, anemia, thrombocytopenia, or abnormal creatinine level. Types 1 and 2 herpes simplex virus IgG and IgM were both negative. Mycoplasma pneumoniae antibody and IgM analysis were equivocal.
We administered cefazolin and methylprednisolone after admission resulting in dusky discolouration of skin and gradual desquamation. Notably, ciliary loss, severe purulent conjunctivitis, synechiae due to pseudomembrane formation and corneal scarring were observed. Prednisolone, levofloxacin, and cyclosporine eye drops were administered, along with mechanical removal of the pseudomembrane.
Skin biopsy demonstrated subepidermal blisters, vacuolar degeneration of the basal layer, scattered necrotic and apoptotic keratinocytes, and perivascular lymphohistiocytic and eosinophilic infiltration in the dermis. These findings are consistent with both enterovirus-induced severe mucocutaneous reactions and drug-induced SJS/TEN. However, neutrophil-rich intraepidermal infiltration in our Blood, wound, and throat swab cultures were unremarkable. The patient recovered well and was discharged after 20 days. One week after discharge, the patient presented to us with mild cutaneous hyperpigmentation and onychomadesis involving all the 10 nails. One month later, the patient was diagnosed with coxsackievirus B5-induced severe mucocutaneous reaction, corroborated by the presence of coxsackievirus B5 in throat swab viral culture. Meanwhile, a lymphocyte transformation test measuring T-cell proliferation against drugs in vitro was performed. The results were negative for acetaminophen, diclofenac, ibuprofen, cephalexin, and trimethoprim-sulfamethoxazole, which greatly reduced the probability of drug-induced SJS/TEN. However, lymphocyte transformation test has limited sensitivity of 60%-70% and specificity of at least 85%. 4 Our case demonstrates the etiological role of coxsackievirus B5 in severe mucocutaneous reactions resembling drug-induced SJS/TEN. Notably, mucosal involvement is a cardinal symptom of drug-induced SJS/TEN. In contrast, ocular and genital mucous involvement is rarely observed in enterovirus infection. Moreover, in severe drug-induced SJS/TEN cases, ocular pseudomembrane formation and corneal scarring may occur, as observed in the present case. 3 Interestingly, similar severe ocular involvement has not been observed in coxsackievirus A6-induced severe mucocutaneous reactions.
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Cutaneous manifestations of enterovirus-induced severe mucocutaneous reactions and drug-induced SJS/TEN may range from maculopapules and vesicles to erosions. However, drug-induced SJS/TEN is characterized by target-like lesions, which were absent in the present case. [1] [2] [3] Complex interactions between viral infections and drug allergy have been observed in some clinical senarios. For example, extensive maculopapular rashes develop in patients with infectious mononucleosis after treatment with ampicillin.
Nervertheless, similar viral-drug interaction has not yet been reported in coxsackievirus infection. 5 To conclude, we report an unusual case illustrating the potential of coxsackievirus B5 to induce clinical symptoms that closely resemble drug-induced SJS/TEN. Thus, we should maintain a high index of suspicion for enterovirus infection while evaluating patients with severe mucocutaneous symptoms.
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There are no conflicts of interest. A 36-year-old unmarried gentleman presented to Rajiv Gandhi Government General Hospital, Chennai, Tamil Nadu, India with multiple episodes of erosive desquamating plaques all over the body, particularly on the flexures and extremities, with intense itching and chronic diarrhea for the last 10 years. On examination, he was short (height: 140 cm), had sparse hair in the axillary, pubic, beard and mustache area but testis and scrotum were normal. He had generalized xerosis, erosive desquamating plaques on the trunk and extremities, predominantly on the flexures, with sparing of the face, palms and soles [ Figure 1a -c]. He also had angular cheilitis, perianal depigmentation with mild erythema, and inguinal and cervical lymphadenopathy.
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His routine blood investigations revealed anemia (hemoglobin: 8 g/dl), thrombocytosis (platelet: 789,000 cells/cu.mm), leukocytosis (16,300 cells/ cu.mm), eosinophilia (2867/cu.mm) and increased lactate dehydrogenase. The serum zinc level was 29 µg/ dl (normal: 70-125 µg/dl), and serum alkaline phosphatase was 122 IU/l (normal: 30-140 IU/l). Histopathology of skin lesion showed hyperkeratosis, subcorneal vesicles, acanthosis, spongiosis and perivascular and peri-appendageal inflammatory infiltrate composed of lymphocytes, neutrophils and some eosinophils, consistent with psoriasiform dermatitis [ Figure 2 ]. In view of the clinical picture, hypozincemia and histologic changes, diagnosis of acquired acrodermatitis enteropathica was made, and the patient was started on oral zinc 3 mg/kg/day and emollients, but there was no improvement of the skin symptoms even after 1 month. At the same time, the patient was being investigated for diarrhea and anemia; his bone marrow biopsy revealed marrow hyperplasia with increased eosinophilic precursors. His colonic biopsy revealed eosinophilic colitis (eosinophil count >25 per high power field) [ Figure 3 ] and esophageal biopsy was reported to be eosinophilic esophagitis (eosinophil count >7 per high power field) [ Figure 4 ]. Fine-needle aspiration cytology of lymph nodes showed reactive lymphadenitis. Repeat absolute eosinophil count done at this point was 3456/cu.mm, after 8 months of initial investigation. His serum immunoglobulin E level was found to be increased (5478 IU/ml). Hence, the final diagnosis was revised to hypereosinophilic syndrome.
